NYSEConsumer DiscretionaryAuto PartsSnapshot 2026-07-23
Reading DAN? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with some volatility in management execution. The current thesis state is intact, but it faces elevated risks in the near term.
The market seems to price in a level of fragility due to weak execution quality, but it is not fully reflecting the potential for re-rating. Valuation appears cheap compared to peers, with a slight expectations gap.
Management is on track to achieve significant cost reductions and is making progress towards increasing adjusted EBITDA. However, the mixed status of sales guidance and recent erratic earnings surprises indicate some uncertainty.
The thesis hinges on the performance of sector bellwethers like ORLY, AZO, and HSAI, which could influence DAN's trajectory. Additionally, any changes in guidance during upcoming calls could significantly impact sentiment.
Over the next 1 to 3 years, DAN's performance will depend on its ability to navigate sector challenges and execute on its financial targets. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The recent merger is expected to enhance growth potential in key markets, which supports a more favorable outlook for the company. There are no significant threats noted at this time.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: This report will provide insights into financial health and progress on strategic goals.
Confirms one read:Earnings report shows strong sales growth and improved margins.
Confirms the other:Earnings report shows sales or margins are lower than expected.
Why it matters: Hitting this goal shows Dana wants to improve its costs and margins.
Confirms:Dana reports achieving $65 million in cost savings by the end of 2026.
Disproves:Cost savings reported below $50 million by year-end 2026.
Why it matters: Closing this deal will create a stronger company and boost growth targets. It is key to Dana's future.
Confirms:The deal will close by Q1 2027. All approvals are in place.
Disproves:The deal is delayed or stopped due to regulatory problems.
Why it matters: New business wins are vital for Dana's growth and sales targets, supporting the Dana 2030 plan.
Confirms:Dana announces new business wins over $200 million. This is in contracts.
Disproves:New business wins are below $200 million. This raises concerns about growth.
Why it matters: Reaching this goal shows good capital use and a focus on shareholder value.
Confirms:Dana reports $300 million in share repurchases by the end of 2026.
Disproves:Share repurchases total less than $200 million by the end of 2026.
Why it matters: This win expands Dana's market presence and could drive future revenue growth.
Confirms:Production for the RAM Dakota program starts on time in early 2028.
Disproves:Production delays or contract problems can affect new business wins.
Why it matters: New contracts can show growth. They can also support Dana's market plan.
Confirms:New business wins over $200 million in net sales were announced.
Disproves:No major new business wins are expected in the next quarters.
Why it matters: This growth is key for Dana's finances and shows how well it operates.
Confirms:Adjusted EBITDA goes up by $200 million from 2025.
Disproves:Adjusted EBITDA growth is under $200 million. This shows weaker results.
Why it matters: A drop in revenue growth signals a potential shift in the Consumer Discretionary sector. This could hurt Dana's performance.
Confirms:Dana's revenue growth falls below the sector median growth rate.
Disproves:Revenue growth stays above the median growth rate for the sector.
Why it matters: Hitting this target shows Dana can manage costs and boost profits.
Confirms:$325 million in cost reductions achieved by the end of 2026.
Disproves:Cost cuts are less than $325 million. This shows operational problems.
Why it matters: If sales guidance goes up, it shows strong demand. It also shows good operations.
Confirms:Sales guidance raised above $7.5 billion for 2026.
Disproves:Sales guidance remains at or below $7.5 billion with no signs of improvement.
Why it matters: A margin over 10% shows strong improvements. It also shows progress toward 2026 goals.
Confirms:Q2 adjusted EBITDA margin was over 10% in the earnings call on August 10, 2026.
Disproves:The adjusted EBITDA margin for Q2 was less than 9%.
Why it matters: Meeting this goal shows good cost control and efficiency, important for growth.
Confirms:Adjusted EBITDA is at least $750 million for 2026, a $200 million rise.
Disproves:Adjusted EBITDA falls short of $750 million for 2026.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
